Diagnosis: Classic Kaposi sarcoma
An older Mediterranean man presents with violaceous patches and plaques on his lower legs, which have been present for several months. The lesions are asymptomatic but have progressively increased in number and size, raising concern for an underlying malignancy. A thorough evaluation is warranted to establish the diagnosis and guide management.
A 68-year-old Mediterranean man presents with violaceous patches and plaques on his lower legs that have been present for the past six months. He reports that the lesions are asymptomatic but have gradually increased in size and number. On physical examination, the following findings are noted:Violaceous patches and plaques: Multiple lesions, some nodular, predominantly on the lower extremities.Distribution: Lesions are symmetrically located on the bilateral calves and ankles.Surface characteristics: Lesions have a smooth surface with no ulceration or crusting.Associated findings: No lymphadenopathy or systemic symptoms reported.
The patient reports that the lesions began as small spots that gradually enlarged and multiplied over the last six months. He denies any history of trauma or sun exposure as potential triggers. His past medical history is significant for hypertension and type 2 diabetes. The patient has no known family history of skin cancer or similar lesions. He has lived in the Mediterranean region for most of his life and is a retired farmer. He has not received any prior treatments for the skin lesions.Onset: Lesions began approximately six months ago.Triggers: No known triggers; no recent travel or new medications.Past medical history: Hypertension and type 2 diabetes.Family history: No family history of skin cancer.Social history: Retired farmer, no tobacco use, moderate alcohol consumption.Exposure history: Long-term resident in a Mediterranean climate.
Acute / First-Line ManagementAntiretroviral therapy: Initiate in patients with HIV-related Kaposi sarcoma; typically, this includes a combination of ART tailored to the patient's viral load and individual tolerance.Local therapy: Intralesional chemotherapy with vinblastine (1 mg/mL) can be considered for localized lesions.Radiation therapy: Palliative radiation can be used for symptomatic lesions or those causing discomfort.Workup and Diagnostic ConfirmationBiopsy: A punch or excisional biopsy of the lesion is essential to confirm the diagnosis histologically, demonstrating spindle cells and angiogenesis.Serology for HHV-8: Testing for human herpesvirus 8 (HHV-8), the viral etiology of Kaposi sarcoma, should be performed.Imaging studies: Consider chest X-ray or CT imaging if systemic involvement is suspected.Long-Term ManagementMonitoring: Regular follow-up for progression or new lesions.Supportive care: Address psychosocial aspects and consider referrals to oncology or palliative care as needed.Patient education: Discuss the nature of the disease, potential treatments, and the importance of adherence to therapy.
Granuloma annulare: Characterized by annular plaques typically on the dorsal surfaces of the hands and feet; often resolves spontaneously.Basal cell carcinoma: Commonly presents as a pearly papule with telangiectasia; biopsy reveals nests of basaloid cells.Dermatofibroma: Firm, raised nodules with a characteristic 'dimple' sign upon lateral compression; usually asymptomatic.Cutaneous T-cell lymphoma: Presents with red, scaly patches or plaques; often associated with pruritus and requires histological examination for confirmation.Psoriasis: Presents with well-defined erythematous plaques covered by silvery scales; often symptomatic with itching.Vasculitis: Can present with purple macules or papules, often associated with systemic symptoms; biopsy shows leukocytoclastic changes.Angiosarcoma: A rare malignant vascular tumor that can present with violaceous lesions; biopsy shows atypical vascular proliferation.Hemangioma: Typically presents as a red or violaceous lesion in childhood; may involute spontaneously.
High-Yield PearlsDemographics: Kaposi sarcoma is more prevalent in older Mediterranean men and those with immunosuppression, particularly HIV.HHV-8: Human herpesvirus 8 is the etiological agent; serological testing is crucial for diagnosis in endemic forms.Lesion characteristics: Violaceous, painless lesions that can progress from macules to nodules; distribution often starts on the lower extremities.Diagnosis: Histopathological examination is essential, revealing spindle cells and vascular proliferation.Management: Treatment may involve antiretroviral therapy for HIV-positive patients, local therapies, and palliative care as needed.Kaposi sarcoma often signals underlying immunosuppression and requires a multidisciplinary approach for effective management.
Tags: Kaposi sarcoma, HHV-8